Country: Netherlands
Language: English
Source: HMA (Heads of Medicines Agencies)
newcastle disease virus 5.5 log10EID50
Merial
QI01AD06
Lyophilisate
Newcastle disease virus / paramyxovirus vaccine
Chicken
2009-11-01
June 2007 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT AVINEW 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of reconstituted vaccine contains: ACTIVE SUBSTANCE : Live Newcastle disease virus, VG/GA strain, at least 5.5 log 10 EID 50 EID50: Egg Infective Dose 50 per cent. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Lyophilisate for suspension for oral and ocular administration and for spraying. Pale, homogeneous lyophilisate. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens (broiler, future layer and future breeder pullets). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In broiler chickens from the age of one day: Active immunisation against Newcastle disease to reduce mortality and clinical signs associated with the disease. Onset of immunity: 14 days after primary vaccination. Duration of immunity induced by the vaccination scheme described under 4.9: protection until the age of 6 weeks. In future layer and future breeder pullets from the age of 4 weeks: Priming for active immunisation against egg drop caused by Newcastle disease before vaccination with an inactivated vaccine (strain Ulster 2C) prior to the beginning of lay. For duration of immunity of full schedule, see SPC of the inactivated booster vaccine. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS Vaccine virus can spread to unvaccinated birds. Infection of unvaccinated birds with the vaccine virus from vaccinated birds does not induce any sign of disease. Moreover, a reversion to virulence trial Read the complete document